Embrapa has developed advanced peanut breeding lines featuring introgressed wild chromosome segments that confer high resistance to late leaf spot and rust. Using marker-assisted backcrossing, these lines combine the high-yield potential of commercial cultivars with novel resistance genes from wild Arachis species, providing a sustainable solution to reduce the impact of destructive fungal diseases in peanut production.
Embrapa has developed advanced peanut breeding lines that incorporate wild chromosome segments to provide high resistance to destructive fungal foliar diseases, specifically late leaf spot and rust. By utilizing an induced allotetraploid donor parent (Arachis stenosperma × A. magna) and a high-yielding commercial cultivar, researchers successfully introgressed novel resistance genes into the cultivated peanut genome. This work expands the genetic diversity of the primary peanut gene pool, offering a critical tool for developing climate-resilient, high-yielding cultivars that require less fungicide intervention.
The technology is at TRL 5. The research has successfully demonstrated the development of agronomically adapted lines through lab-based marker-assisted backcrossing and field validation of resistance traits. While these lines have shown high-yield potential and resistance in field assays, they are currently in the stage of advanced breeding and evaluation for potential commercial release.
Embrapa is Brazil’s national agricultural research enterprise under the Ministry of Agriculture, combining basic and applied R&D with large-scale field operations across dozens of research centers and experimental farms nationwide. Industry engages through regional hubs that co-locate laboratories with test plots and demonstration farms, enabling joint trials, cultivar evaluation, and validation in production environments. Dedicated technology transfer units structure licensing, germplasm access, and sponsored research, while extension interfaces translate results to producers through training and digital advisory tools. Research is supported by Brazilian federal appropriations, complemented by competitive funding from national science and innovation agencies and international partners.